GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
THRESHOLD PHARMACEUT (THLD) [hlAlert]

Threshold is focused on the discovery, development, and commercialization of small molecule therapeutics based on `Metabolic Targeting.` This
approach targets abnormal glucose metabolism - a fundamental property of most solid tumors and other diseases. The company's initial focus is the treatment of cancer and benign prostatic hyperplasia, a disease characterized by overgrowth of the prostate.
( Total: 10 Current Stock Recommendations )
THRESHOLD PHARMACEUT   (10)
Hold 20% Buy 80%
Related companies
PROLOR Biotech, Inc.   (5)
Buy 100%
China Biologic ...   (2)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Insmed, Inc.   (6)
Buy 100%
Accelrys, Inc.   (5)
Buy 100%
Qlt Inc.   (5)
Buy 100%
Lannett Co Inc   (3)
Buy 100%
Emergent ...   (5)
Buy 100%
Talecris ...   (4)
Buy 100%
Trius Therapeutics, ...   (9)
Buy 100%
Filter by Gains:   
  
Rating:
Buy THLD
up 9.09 %
THRESHOLD PHARMACEUT (THLD) upgraded to Overweight by Piper Jaffray
Wednesday,  Feb 20, 2013  8:25 AM ET

Rating:
Hold THLD
3 Months Gains
up 9.78 %
THRESHOLD PHARMACEUT (THLD) rated Neutral by Piper Jaffray
Friday,  Jan 18, 2013  8:25 AM ET

Rating:
Buy THLD
down 30.14 %

Rating:
Buy THLD
down 32.16 %

Rating:
Buy THLD
down 30.14 %

Rating:
Buy THLD
down 34.93 %
THRESHOLD PHARMACEUT (THLD) rated Outperform by William Blair
Tuesday,  Jul 10, 2012  11:25 AM ET

Rating:
Buy THLD
down 36.17 %

Rating:
Buy THLD
down 26.12 %

Rating:
Buy THLD
down 11.18 %

Rating:
Buy THLD
up 318.60 %

Rating:
Hold THLD
THRESHOLD PHARMACEUT (THLD) rated Hold by Fortis Bank
Tuesday,  May 13, 2008  10:25 AM ET

Rating:
Hold THLD
Threshold Pharmaceuticals, Inc. (THLD) rated Hold
Monday,  Dec 3, 2007  9:25 AM ET

Your Recent Stocks
SymbolLastChange
THLD 5.50   0.00 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy
Copyright © 2007 GainersToday.com. All rights reserved.